Table 5.
Summary of a randomized clinical trial of moxibustion.
| References | Design | Sample size | Interventions | Main outcomes | Acupuncture points |
|---|---|---|---|---|---|
| [144] | RCT | 92 | Treatment group: warm acupuncture Control group: estradiol valerate tablet. |
1. Pregnancy rate: treatment group—34.78% (16/50); control group—13.04% (6/50) 2. Endometrial thickness after treatment: treatment group—9.89 ± 2.06 mm; control group—8.02 ± 2.03 mm |
Guanyuan (RN4), Zigong (EX-CA1) Zhongji (RN3), Yinjiao (RN7) |
|
| |||||
| [145] | RCT | 136 | Treatment group: warm acupuncture + Zhen qi decoction Control group: estradiol valerate. |
1. Pregnancy rate: treatment group—63.24% (43/68); control group—41.18% (28/68) 2. Endometrial thickness after treatment: treatment group—9.37 ± 1.53 mm; control group—7.49 ± 1.38 mm |
Guanyuan (RN4), Zhongji (RN3) Sanyinjiao (SP6), Zusanli (ST36) |
|
| |||||
| [146] | RCT | 56 | Treatment group: warm acupuncture Control group: antibiotics and flexor progesterone. |
1. Clinical pregnancy rate: treatment group—46.3%; control group—20.7% 2. Endometrial thickness after treatment: treatment group—9 ± 2 mm; control group—9 ± 3 mm |
Zhongwan (RN12), Tianshu (ST25) Guanyuan (RN4), Zhongji (RN3) Zigong (EX-CA1), Liangqiu (ST34) Zusanli (ST36), Shangjuxu (ST37) Xiajuxu (ST39) |
|
| |||||
| [148] | RCT | 60 | Treatment group: thunder fire moxibustion Control group: ovulation monitoring |
Pregnancy rate: treatment group—50.00% (15/30); control group—23.30% (7/30) | Guanyuan (RN4), Qihai (RN6) |
|
| |||||
| [149] | RCT | 100 | Treatment group: estradiol valerate and thunder fire moxibustion Control group: estradiol valerate |
1. Pregnancy rate: treatment group—40.00% (20/50); control group—20.00% (10/50) 2. Endometrial thickness after treatment: treatment group—10.56 ± 2.88 mm; control group—7.86 ± 2.16 mm |
Shenque (RN8), Guanyuan (RN4) Zigong (EX-CA1), Zhongji (RN3) Guilai (ST29), Qihai (RN6) |
|
| |||||
| [150] | Retrospective study | 60 | Treatment group: wheat moxibustion Control group: hormone replacement cycle intima; corpus luteum. |
1. Pregnancy rate: treatment group—33.33% (10/30); control group—23.33% (7/30) 2. Endometrial thickness after treatment: treatment group—9.28 ± 1.15 mm; control group—8.35 ± 1.14 mm |
Qihai (RN6), Guanyuan (RN4) Zigong (EX-CA1), Zusanli (ST36) |
|
| |||||
| [151] | RCT | 80 | Treatment group: conventional acupuncture and wheat grain moxibustion Control group: levonorgestrel |
1. Total efficiency: treatment group—97.5% (39/40); control group—82.5% (33/40) 2. Endometrial thickness after treatment: treatment group—6.7 ± 0.7 mm; control group—7.6 ± 0.8 mm |
Guanyuan (RN4), Zigong (EX-CA1) Zhongji (RN3), Sanyinjiao (SP6) Diji (SP8), Shiqizhui (EX-B8) Ciliao (BL32) |
|
| |||||
| [154] | RCT | 70 | Treatment group: EA + ginger moxibustion isolation Control group: letrozole + HCG |
1. Pregnancy rate: treatment group—56.25% (18/32); control group—30.3% (10/32) 2. Endometrial thickness after treatment: treatment group—0.89 ± 0.14 mm; control group—0.78 ± 0.10 mm |
Zigong (EX-CA1), Guilai (ST29) Sanyinjiao (SP6), Taichong (LV3) Hegu (LI4), Qihai (RN6) Dahe (KI12), Luanchao (TF2) Zusanli (ST36), Taixi (KI3) Guanyuan (RN4), Shenque (RN8) Wushu (GB27), Zhongji (RN3) |
|
| |||||
| [155] | RCT | 80 | Treatment group: invigorating qi-tonifying kidney Chinese medicine + Ren Mai moxibustion Control group: estradiol + dydrogesterone |
1. Pregnancy rate: treatment group—67.5% (27/40); control group—42.5% (17/40) 2. Total efficiency: treatment group—87.5% (35/40); control group—65.0% (26/40) |
Shenque (RN8), Qugu (RN2) Zhongji (RN3), Guanyuan (RN4) |
|
| |||||
| [156] | RCT | 210 | Treatment group 1: heat-sensitive moxibustion + acupoint injection Treatment group 2: heat-sensitive moxibustion Control group: cefoxitin sodium |
Endometrial thickness after treatment: treatment group 1—10.0 ± 0.98 mm; treatment group 2—9.24 ± 0.87 mm; control group—7.89 ± 1.02 mm | Yaoyangguan (DU3) Guanyuan (RN4), Qihai (RN6) Shenshu (BL23), Sanyinjiao (SP6) Yinlingquan (SP9), Zigong (EX-CA1) |